Nexcida Therapeutics, Inc. — Form D
Nexcida Therapeutics, Inc. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-06-23. The offering totals $21.3M, of which $2.8M was reported sold. Industry: Other.
Offering
- Filed: 2015-06-23
- Form: D
- Accession: 0001645368-15-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $21.3M
- Amount sold: $2.8M
- Remaining: $18.5M
- Investors: 5
- Date of first sale: 2015-06-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-242328
Issuer
- Name: Nexcida Therapeutics, Inc.
- CIK: 0001645368
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 70 WILLOW ROAD, MENLO PARK, CA, 94025
- Phone: 6503255156
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Brent Ahrens | Director | Edina, MN |
| Yigong Ge | Director | Menlo Park, CA |
| Patrick Heron | Director | Philadelphia, PA |
| David Socks | Director | Menlo Park, CA |
| CHEN YU | Director | PALO ALTO, CA |
| David Socks | Executive Officer | Menlo Park, CA |
| David Socks | Promoter | Menlo Park, CA |
More